Research ArticleCLINICAL INVESTIGATIONS
Histopathologic Validation of 3′-Deoxy-3′-18F-Fluorothymidine PET in Squamous Cell Carcinoma of the Oral Cavity
Esther G.C. Troost, Johan Bussink, Piet J. Slootweg, Wenny J.M. Peeters, Matthias A.W. Merkx, Albert J. van der Kogel, Wim J.G. Oyen and Johannes H.A.M. Kaanders
Journal of Nuclear Medicine May 2010, 51 (5) 713-719; DOI: https://doi.org/10.2967/jnumed.109.071910
Esther G.C. Troost
Johan Bussink
Piet J. Slootweg
Wenny J.M. Peeters
Matthias A.W. Merkx
Albert J. van der Kogel
Wim J.G. Oyen
Johannes H.A.M. Kaanders

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 51, Issue 5
May 2010
Histopathologic Validation of 3′-Deoxy-3′-18F-Fluorothymidine PET in Squamous Cell Carcinoma of the Oral Cavity
Esther G.C. Troost, Johan Bussink, Piet J. Slootweg, Wenny J.M. Peeters, Matthias A.W. Merkx, Albert J. van der Kogel, Wim J.G. Oyen, Johannes H.A.M. Kaanders
Journal of Nuclear Medicine May 2010, 51 (5) 713-719; DOI: 10.2967/jnumed.109.071910
Histopathologic Validation of 3′-Deoxy-3′-18F-Fluorothymidine PET in Squamous Cell Carcinoma of the Oral Cavity
Esther G.C. Troost, Johan Bussink, Piet J. Slootweg, Wenny J.M. Peeters, Matthias A.W. Merkx, Albert J. van der Kogel, Wim J.G. Oyen, Johannes H.A.M. Kaanders
Journal of Nuclear Medicine May 2010, 51 (5) 713-719; DOI: 10.2967/jnumed.109.071910